Diabetes

This hub delivers an in-depth, evidence-based exploration of diabetes mellitus, uniting authoritative articles on disease mechanisms, diagnosis, management, and prevention. Covering both type 1 and type 2 diabetes, as well as rare and secondary forms, this collection provides readers with comprehensive information on risk factors, clinical presentation, complications, and the latest advances in research and technology. Topics include the impact of nutrition and lifestyle, pharmacological and non-pharmacological therapies, monitoring strategies, acute and chronic complications, and innovative developments such as artificial pancreas systems and digital health tools. These resources also examine the psychosocial aspects of living with diabetes and offer practical guidance for both patients and healthcare professionals. Whether you seek foundational knowledge or current developments in diabetes care, this hub serves as a trusted, up-to-date reference.

Okra and Diabetes: What Research Says About Its Blood Sugar Control Effects

Emerging evidence from clinical and mechanistic studies reveals how okra’s natural compounds lower blood sugar, balance lipids, and support overall metabolic health in diabetes.

Diabetes and Skin Problems

How does Gestational Diabetes Affect the Baby?

The Impact of Glucagon on Diabetes Management

What is Diabetic Nephropathy?

Artificial Pancreas Systems: The Future of Diabetes Management?

Vitamin D and Type 2 Diabetes

Diabetes and Sleep

Treatment and Prognosis for Diabetic Mastopathy

What is Diabetic Hypoglycemia?

Understanding MODY 5: A Rare Genetic Form of Diabetes

Diabetic Neuropathy Treatments

See more featured articles »

Diabetes and Vision

How Baking Soda Affects People with Type 2 Diabetes

What Causes Diabetes?

Is a Plant-Based Diet Good for Type 2 Diabetes?

Low Sugar Foods for Diabetes

What is a Diabetic Coma?

Diabetic Retinopathy Symptoms

Diabetic Hypoglycemia Treatments

Encapsulating Islet Cells for the Treatment of Diabetes

Diabetic Neuropathy Symptoms

Diabetic Retinopathy Diagnosis

What is Diabetes?

The Risks of Prediabetes

Diabetic Mastopathy Diagnosis

Harnessing the Power of AI: Predicting Diabetes Onset Before It Strikes

Diabetes and Periodontitis

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

What is Diabetic Neuropathy?

Advanced Diabetic Ketoacidosis

Diabetes Symptoms

Diabetes in Men

What is Diabetic Retinopathy?

Diabetic Mastopathy: Complication of Diabetes Mellitus

Diabetes Risk Factors

Risks to Infants of Diabetic Mothers

How Does Semaglutide Work to Lose Weight?

Diabetic Emergencies: What to Do

Bionic Advancements: The Next Generation of Insulin Delivery Devices

Walking After Meals: Small Habit, Big Metabolic Gains

Pins and Needles and Diabetes

Diabetic Retinopathy Treatments

Animals That Can Detect Hypoglycemia

What Causes Diabetic Nephropathy (Kidney Disease)?

Diabetic Hypoglycemia Etiology

Diabetes Types

Nonketotic Hyperosmolar Coma

Epigenetic Mechanisms in Type 2 Diabetes

What is Diabetic Ketoacidosis?

Diabetes Screening

Navigating Insulin Pumps: Technology, Benefits, and What’s Next

Red Blood Cell Morphology Changes in Diabetes

Does the Keto Diet Increase the Risk of Diabetes?

Hypoglycemic Unawareness

Effects of Hyperglycemia on the Vascular System

Diabetic Nephropathy Symptoms

Research into a Cure for Diabetes

Diabetic Ketoacidosis Causes

Diabetic Retinopathy Risk Factors

Diabetes in Men versus Women

Diabetes Management

Diabetic Coma Severe Hypoglycemia

What is HbA1c?

What is HbA1C Testing?

Diabetic Neuropathy Diagnosis

Causes of Foot Pain

What are Nightmares and Why Do They Occur?

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

Alcohol and Diabetes

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Can I reverse my prediabetes naturally

Diabetic Coma Treatments

Diabetes and Mucormycosis

Diabetes and Pregnancy

COVID-19 and Diabetes

Genetic Testing for Diabetes

The Future of Diabetes Treatment

Cause of Diabetic Coma

Diabetes and Wound Healing

Supplements for Diabetes

Diabetic Foot Problems

Diabetic Nephropathy Treatment

Diabetes Diagnosis

Diabetes Complications

History of Diabetes

Does the 'Stomach Flu' Vaccine Prevent Type I Diabetes?

Adiponectin and Diabetes

Diabetes Pathophysiology

Diabetic Neuropathy Pathogenesis

Latest Diabetes News and Research

Polygenic embryo testing raises ethical concerns beyond disease prevention

For more than four decades, in vitro fertilization (IVF) has helped families have children. Scientists estimate that more than 10 million people worldwide have been born through IVF and related assisted reproductive technologies, according to the International Committee for Monitoring Assisted Reproductive Technologies.

31 Mar 2026

What happens when more of your exercise is vigorous instead of moderate?

In a large UK Biobank analysis, a higher proportion of vigorous physical activity relative to total activity volume was associated with lower risks of eight major chronic diseases and all-cause mortality, even after accounting for overall activity volume. Device-based data suggested that activity intensity generally offered greater preventive potential than total volume alone across most outcomes.

31 Mar 2026

Living in food deserts linked to complications after breast reconstruction surgery

For patients undergoing breast reconstruction, residing in a food desert may be associated with an increased risk of certain complications after surgery, reports a study in the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

31 Mar 2026

Treating autonomic dysfunction can relieve symptoms of treatment-resistant depression

Consider a house with the water main half shut. The faucets sputter. The toilet runs all night. The garden wilts. You could call a plumber for the faucet, a landscaper for the garden, a different plumber for the toilet, and every one of them would fix something while fixing nothing.

31 Mar 2026

How swapping unhealthy foods can significantly reduce your heart risk

More than half of adults and about 60% of children in the U.S. have unhealthy diets, which can contribute to higher rates of health factors such as high blood pressure and obesity, and lead directly to poor health outcomes including deaths from cardiovascular disease and other chronic conditions, according to the American Heart Association.

31 Mar 2026

Lifestyle care in primary clinics allows for safe diabetes deprescribing

A new research study provides real-world evidence that deprescribing glucose‑lowering medications is both feasible and safe when patients with type 2 diabetes receive lifestyle‑informed care in primary care settings.

31 Mar 2026

ACLM launches project remission for Type 2 diabetes

The American College of Lifestyle Medicine (ACLM) announces the launch of Project Remission: A Lifestyle Medicine Approach to Type 2 Diabetes, a national digital film series developed in partnership with Content With Purpose (CWP).

31 Mar 2026

How gut imbalance may drive obesity, diabetes, and heart disease

A new review argues that gut dysbiosis is closely linked to metabolic dysfunction through intertwined effects on inflammation, oxidative stress, gut barrier integrity, microbial metabolites, and epigenetic regulation. It also highlights microbiome-targeted strategies such as high-fiber diets, probiotics, prebiotics, postbiotics, exercise, and fecal microbiota transplantation as promising ways to support metabolic health.

30 Mar 2026

Modern lifestyle amplifies genetic risk for type 2 diabetes

Some people have a greater genetic risk than others of developing type 2 diabetes. Now, more of these at-risk people are actually developing diabetes than previously.

30 Mar 2026

Measuring heart fat with AI improves cardiovascular risk prediction

Mayo Clinic research identified a powerful new way to improve the prediction of a patient's long-term cardiovascular disease risk by enhancing a routinely performed imaging test with artificial intelligence (AI).

30 Mar 2026

Antidepressant fluvoxamine reduces long COVID fatigue in clinical trial

A randomized placebo-controlled trial found that fluvoxamine, a low-cost antidepressant, reduced fatigue and improved quality of life in adults with long COVID, offering one of the first evidence-based medication options for this persistent condition. In contrast, metformin did not provide meaningful benefit for established long COVID fatigue, highlighting fluvoxamine as the more promising treatment candidate in this study.

30 Mar 2026

Time-restricted eating improves hormone levels in women with PCOS

Polycystic ovary syndrome, or PCOS, affects as many as 18% of all childbearing-age women. The condition occurs when a woman's body produces too much of a group of hormones called androgens, chiefly testosterone. Menstrual irregularity, obesity and even infertility can result.

30 Mar 2026

AI eye exams accurately identify heart disease risk during routine visits

A new system that uses artificial intelligence (AI) to assess cardiovascular risk based on images of the eye captured during eye exams demonstrated strong correlation with a standard cardiovascular risk assessment, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

30 Mar 2026

Triglyceride-lowering drug olezarsen fails to reduce arterial plaque

Despite experiencing significant reductions in triglycerides, patients with triglycerides over 150 mg/dL and a high risk of atherosclerosis did not experience any significant change in the amount of non-calcified plaque in their coronary arteries after taking the triglyceride-lowering drug olezarsen, in a one-year sub-study presented at the American College of Cardiology's Annual Scientific Session.

30 Mar 2026

Short bursts of vigorous activity can lower risk of major diseases

People who get just a few minutes of vigorous activity daily are less likely to develop eight major diseases, including arthritis, heart disease and dementia, according to research published in the European Heart Journal today (Monday).

29 Mar 2026

Novel vFFR method performs similar to invasive coronary assessment

A novel, minimally invasive method of determining whether fatty deposits in a coronary artery are restricting blood flow to a patient's heart performed similarly to the standard, more-invasive procedure in a large multi-country European randomized trial presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

29 Mar 2026

AI-based tool matches standard method for coronary blood flow assessment

A novel, minimally invasive computer software-based method that uses artificial intelligence to determine whether plaques in a coronary artery are restricting blood flow to the patient's heart performed similarly to the standard, more invasive wire-based procedure, according to a large international randomized trial presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

29 Mar 2026

Angioplasty improves symptoms in chronic total coronary occlusion patients

In what is believed to be the first randomized placebo-controlled trial of its kind, patients with a chronic total blockage of a coronary artery who received a nonsurgical procedure to reopen the artery showed statistically significant reductions in chest pain and improvements in quality of life compared with patients who received a placebo procedure.

29 Mar 2026

Intensive LDL cholesterol-lowering shows major benefits for heart disease patients

Using cholesterol-lowering medications more intensively to achieve a more aggressive target for low-density lipoprotein cholesterol (LDL-C) reduced the rate of major cardiovascular events by one-third among patients with atherosclerotic cardiovascular disease (ASCVD), according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

28 Mar 2026

Evolocumab reduces cardiac events in high-risk diabetic patients

The cholesterol-lowering therapy evolocumab reduced the risk of major adverse cardiac events by nearly one-third among patients who had no known significant atherosclerosis and had diabetes, according to a study presented at the American College of Cardiology's Annual Scientific Session.

28 Mar 2026